Press Releases

• Leading manufacturer of custom-engineered control building solutions designed to protect critical infrastructure assets
• Expands nVent’s enclosures portfolio in new applications and enhances systems protection capability
• Strengthens nVent’s position with the electrification of everything in high-growth verticals including power utilities, data centers and renewables
• Expect transaction to be accretive to adjusted EPS in the first year after completing the... (continue reading...)

• Quarterhill will supply and maintain iTHEIA™ video-based AI traffic count and classification systems at 17 sites across North Dakota.
• Vehicle count and classification data from iTHEIA, an advanced AI-powered, video-based system, will provide essential data for highway planning, design, maintenance, and management in the state.

TORONTO, June 6, 2024 /PRNewswire/ - Quarterhill Inc. ("Quarterhill" or the "Company") (TSX: QTRH) (OTCQX: QTRHF), announced today that it... (continue reading...)

SAN MATEO, Calif., June 6, 2024 /PRNewswire/ -- Symmetry Systems, the data+AI security company, today announced it has been named as a Strong Performer in the 2024 Gartner® Peer Insights™ Voice of the Customer for Data Security Posture Management report.1

"The 'Voice of the Customer' is a document that synthesizes Gartner Peer Insights' reviews into... (continue reading...)

Industry leading expert in data, analytics and AI solutions for global life sciences companies to lead the Commercial Solutions division of ConcertAI

CAMBRIDGE, Mass., June 6, 2024 /PRNewswire/ -- ConcertAI, the leader in oncology Real-World Data (RWD) and AI SaaS Solutions for healthcare and life sciences, today announced Nick Jones, D.Phil., as the SVP and General Manager of the company's Commercial Solutions division. Dr. Jones will focus on bringing new and... (continue reading...)

– US subgroup in the phase 3 KONFIDENT trial demonstrates median time to treatment of 38 minutes and time to beginning of symptom relief 1.3 hours –

– Despite growing use of long-term prophylaxis therapies in the US on-demand treatment prescription volumes stay stable and non-prescription healthcare costs for management of HAE remain substantial –

CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)-- KalVista Pharmaceuticals, Inc. (NASDAQ: KALV),... (continue reading...)